Can identifying a cause for lupus help reverse the disease? — The Autoimmune Registry
www.autoimmuneregistry.org
Over 1.5 million people in the U.S. are affected by lupus, and the cause of this autoimmune disease remains unclear. However, the latest discovery of what may be the cause of lupus could potentially lead to new treatments that can reverse the disease.

Scientists from Northwestern Medicine and Brigham and Women’s Hospital have noticed that lupus patients exhibit changes in multiple molecules in their blood. These changes, in turn, lead to a lack of activation of a pathway managed by the aryl hydrocarbon receptor (AHR). The AHR regulates the cells’ response to environmental agents such as pollutants, bacteria, or metabolites. When the activation of AHR is lacking, T peripheral helper cells—or disease-promoting immune cells—become abundant and promote the production of disease-causing autoantibodies.

Through this discovery, Dr. Jaehyuk Choi and his team hypothesized that activating the AHR pathway with small molecule activators could reduce the number of disease-causing cells. Investigators tested this hypothesis by injecting these AHR small molecule activators into the blood samples of lupus patients. Doing so seemed to reprogram the lupus-causing cells into a cell type called Th22, which may help reverse the damage caused by the disease.